Skip to main content

Published locations for Standard first‐line chemotherapies for indolent B‐cell lymphoma impose varying risks for a second cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Standard first‐line chemotherapies for indolent B‐cell lymphoma impose varying risks for a second cancer

User login

  • Reset your password
  • /content/standard-first-line-chemotherapies-indolent-b-cell-lymphoma-impose-varying-risks-second
  • /hematology-oncology/article/262012/b-cell-lymphoma/standard-first-line-chemotherapies-indolent-b
  • /breast-cancer-icymi/article/262012/breast-cancer/standard-first-line-chemotherapies-indolent-b-cell
  • /b-cell-lymphoma-icymi/article/262012/b-cell-lymphoma/standard-first-line-chemotherapies-indolent-b